Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid

• Conditions: Thyroid

• Registration Number: NCT05501041
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2022-08-12
• Study First Submitted QC: 2022-08-12
• Study First Posted: 2022-08-15
• Study Start: 2022-08-22
• Status Verified: 2023-09
• Last Update Submitted: 2023-09-08
• Last Update Posted: 2023-09-11
• Primary Completion: 2025-08
• Study Completion: 2025-08

Recruitment & Eligibility

• Status: ENROLLING_BY_INVITATION
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Undergoing Radiofrequency Ablation (RFA) for symptomatic thyroid nodule(s).

Read More

Exclusion Criteria

• Decline to participate in research.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in symptoms before and after ablation	Baseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment	Measured using a modified 6-item SYS questionnaire that objectively measures patient symptoms on a scale of 0=none, 1=moderate, 2=severe

Trial Locations

Locations (1)

Mayo Clinic Rochester; 🇺🇸 Rochester, Minnesota, United States